跳至主要内容
临床试验/NCT03572088
NCT03572088已完成2 期

Terlipressin Infusion During Whipple Procedure: Effect on Blood Loss and Transfusion Needs

Assiut University0 个研究点目标入组 40 人开始时间: 2016年5月最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
40
主要终点
Intraoperative blood loss

研究概览

简要总结

The present study aims to look at the effect of terlipressin infusion on blood loss and blood transfusion needs during Whipple procedure

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients older than 18 years of age,
  • ASA classification class I and II,
  • Patients assigned for Whipple procedure.

排除标准

  • Preoperative renal failure,
  • Severe liver dysfunction (Child-Turcotte-Pugh grade C),
  • Hyponatremia (Na+ <132mmol/l),
  • Severe valvular heart disease,
  • Heart failure,
  • Symptomatic coronary heart disease,
  • Bradycardic arrhythmia (heart rate < 60/min),
  • Peripheral artery occlusive disease (clinical stadium II-IV),
  • Uncontrolled arterial hypertension (Blood pressure >160/100mmHg despite intensive treatment),
  • Pregnancy.

研究组 & 干预措施

Terlipresssin

Active Comparator

Terlipressin was started at the beginning of surgery, just after exposure of the portal vein and getting a basal portal pressure reading, as an initial bolus dose of 1 mg over 30 minutes (1 mg/50 ml normal saline at a rate of 100 ml/h) followed by a continuous infusion of 2 μg/kg/h(1 mg/50 ml at a rate equal to wt/10 ml per hour) and weaned in the postoperative period over 4 hours.

干预措施: Terlipressin (Drug)

Control

Placebo Comparator

patients received the same volume of normal saline for the same duration (50 ml normal saline at a rate of 100 ml/h followed by a continuous infusion of 50 ml at a rate equal to wt/10 ml per hour and weaned in the postoperative period over 4 hours)

干预措施: normal saline (Drug)

结局指标

主要结局

Intraoperative blood loss

时间窗: intaoperative periods

Amount of intraoperative blood loss in ml

次要结局

  • portal pressure changes(intaoperative periods)
  • ICU stay(postoperative periods)
  • Patients needing blood transfusion(intaoperative periods)
  • Red blood cell units transfused(intaoperative periods)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Magdy Mohammed Mahdy Sayed

Assiut-Egypt

Assiut University

相似试验